GlobalCONTACT
ISSUE 03/2025
Overview
Report: 20 years JenVis Research // Technology: Novel bioinspired polymeric material // Manufacturing: The legacy lab // Fitting Background: Zernike & HOA // Myopia Management
// Business & Marketing: Polite or cowardly?
NEWS
The Eye Consortium adds Bausch + Lomb as partner
The Eye Consortium (TEC), an alliance group for independent practices, has formed a new Elite Vendor partnership with Bausch + Lomb to help advance TEC’s ongoing commitment to deliver programs and resources that help the alliance’s member doctors elevate both the patient experience and practice profitability. “In response to the overwhelming interest from our membership,…
Prevent Blindness names Matt MacDonald as Chair of Board of Directors
Prevent Blindness, has announced that Matt MacDonald, president and global head of managed care, EyeMed Vision Care, was appointed chair of its board of directors on November 14, at the 2025 Prevent Blindness annual board meeting here. MacDonald succeeds Jim McGrann, CEO of Advancing Eyecare, who was named an emeritus member of the board. At…
Custom contact lens manufacturer Scotlens unveils new brand identity
Scotlens, a leading custom contact lens manufacturer, has unveiled its refreshed brand identity at the Hospital and Specialty Optometrists Conference (8–9 November 2025). The rebrand follows its acquisition by Contact Lens Precision Laboratories (CLPL) six months ago and aligns Scotlens with CLPL and sister company Ultravision, which rebranded in 2024. “This integration strengthens our mission…
ONE by ONE Recycling program collects used contact lens
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced its ONE by ONE Recycling program has collected a total of 691,180 pounds, or 114,037,136 units, of used contact lens, eyecare and lens care materials in the United States. The program, created in collaboration with international recycling leader TerraCycle, continues to…
LENZ Therapeutics shares 3rd quarter financial results
LENZ Therapeutics, Inc. the pharmaceutical company focused on the commercialization of recently FDA-approved VIZZ (aceclidine ophthalmic solution) 1.44%, has announced financial results for the third quarter ending September 30, 2025, as well as recent corporate highlights. Highlighted among those was the FDA approval in late July of VIZZ, an aceclidine-based eye drop for the treatment…
ARTICLES
20 years of JenVis Research
International conference for optometry and vision science The Jena Vision Conference, held from 31 October to 2 November 2025, marked the 20th anniversary of the Jena Vision Research Institute. Over 300 guests, 25 speakers from 6 countries came together to discuss current developments in optometry and vision science – and to look back on two…
Myopia management
A guide through awareness, science and practice Short-sightedness, medically known as myopia, has gradually and continuously crept into our school classrooms, families and optometry practices over the past decades. It is not a ‘trend’ but a global challenge that has a concrete impact on everyday working life. A fundamental question for optometrists and ophthalmologists is:…
Vision impossible?
Holy grail aberrations What I like about the contact lens field – as opposed to general medicine, for instance – is that we can ‘create things.’ Beautiful things. General medicine and eye care is more about dealing with existing conditions, while in the contact lens field, we can create vision. How cool is that? We…
The legacy lab
Too much “baggage” for success? Legacy labs sometimes rely on outdated technologies and processes, even when new equipment has already been acquired. This has many undesirable effects on efficiency and makes it difficult to compete with start-ups that enter the market with the aim of keeping pace with changes in the production landscape. However, it…
Novel bioinspired polymeric material
Concepts and applications for functionalized contact lenses and keratoprostheses The development of biofunctionalized materials represents a paradigm shift in contact lens technology. By mimicking natural biological structures such as mucins through synthetic (glyco)polymers, researchers are creating advanced materials with tailored properties for improved wearing comfort, therapeutic drug delivery, enhanced biocompatibility, and diagnostic applications. These biomimetic…
Pediatric Scleral Lenses
The care and treatment of vision problems in childhood is particularly challenging, especially when conventional visual aids are not sufficient. A 21-year retrospective study by Carrasquillo et al. highlights the long-term effects and benefits of scleral lenses in pediatric care.
LETTER
Employee, where are you?
Are you having trouble finding employees? And to keep them? There’s a specter haunting the EU – and unfortunately, it’s very real: The shortage of skilled workers. And it’s particularly noticeable in some EU countries. That’s because demographic change is in full swing here – and often more advanced than in other regions of the world.